Biography
Prof Emily Callander is a health economist and health services researcher specialising in maternal, women’s and child health. Emily is a Professor, and Head of Discipline for Health Services Management in the School of Public Health. She leads a Women’s Economics and Value-Based Care research program, externally funded by a number of NHMRC and MRFF grants, which collaborates widely to provide the economic evidence base to guide health service and policy decision-making. This includes undertaking economic evaluation alongside randomised controlled trials, measuring costs and outcomes with real-world linked administrative data, and conducting local-health service level economic modelling. Emily sits on a number of maternal health state government committees; and is a member of the Pharmaceutical Benefits Advisory Committee Economics Subcommittee. Her mission is to improve the equity and efficiency of health services and systems by embedding economic evidence into decision-making.
Abstract
There is a vast volume of data collected as a part of day to day delivery of health services. Due to the activity based funding nature of the Australian health care system, these health data also include detailed information on the health services utilised by patients. Such routine administrative data thus provides many benefits for health economic evaluations that require quantification of health service use. This presentation will illustrate the use of routine health service data as a part of two evaluation activities – one a hospital-level service evaluation, and the other a nation-wide implementation program evaluation. It will cover the benefits and challenges associated with use of administrative data, and the practical steps required to access and utilise such data. This talk will be pitched to those who do not have prior experience with use of health administrative data, and it also will not assume health economics expertise.
Latest Resource
-
Webinar recording: The economics of trials – reducing waste in research
-
Webinar recording: Identifying and addressing trial design issues early
-
ACTA Consumer Remimbursement and Remuneration Policy
-
ACTA Webinar: Pre-trial VOI analyses to guide trial prioritisation and data collection
-
Webinar recording: Patient reported outcome endpoints: Optimal development, collection, analysis planning & reporting:
-
Webinar recording: APT Virtual Clinic – ACT-GLOBAL Adaptive Platform Trial for Stroke
-
Workshop: How to better develop cross-network collaborations and linkages
-
The processes involved in a Data and Safety Monitoring Board/Committee with special reference to the role of the various statisticians
-
Webinar recording: Quantifying Equity Impacts
-
ACTA 2022-2023 Annual Report
-
ACTA Whistleblower Policy
-
HEAT webinar recording: Design of economic evaluations along the development process
-
Workshops and Virtual Clinics on Adaptive Platform Trials
-
Webinar recording: APT Virtual Clinic – the BAT and PASSPORT Trials
-
Exploring greater partnership between Clinical Trial Networks, Clinical Quality Registries and Trial Coordinating Centres with Industry
-
HEAT Webinar Recording-Flexible survival models and why we (might) need them
-
Recommendations to improve cultural and linguistic diversity in clinical trials
-
Adaptive Platform Trial Summaries
-
Approaches to prioritising research
for clinical trial networks: a scoping review -
HEAT Webinar Recording- Economic Evaluation Alongside Adaptive Trials
-
ACTA 2021-2022 Annual Report
-
Effective strategies to manage data integrity risks webinar
-
The Data Lifecycle: Ethical use of data webinar
-
Transparency in data analyses webinar
-
Economic evaluation alongside cluster trial – webinar recording
-
Development of the Consumer Involvement and Engagement Toolkit
-
Activities supporting the growth of Clinical Trial Networks in Australia
-
A pilot study to prospectively estimate the health and economic return on research investment
-
Strengthening the capacity, efficiency and effectiveness of Clinical Trials Networks: Activity Overview 2017–2021
-
ACTA 2020-2021 Annual Report
-
MEDIA RELEASE: ACTA appoints Prof Steve Webb as its new Chair and Ian Wilson as Additional Independent Director
-
Official Opening of the 2020 ACTA Summit: Minister’s Address
-
ACTA Year in Review: Financial Year 2019-2020
-
Statistical Analysis Plan (SAP)
-
ACTA Board Charter
-
ACTA Constitution